First Manhattan CO Abbott Laboratories Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

A detailed history of First Manhattan CO transactions in Abbott Laboratories stock. As of the latest transaction made, First Manhattan CO holds 79,487 shares of ABT stock, worth $10.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

79,487

Previous 95,222 16.52%

Holding current value

$10.5 Million

Previous $9.89 Million 8.41%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $1.57 Million - $1.86 Million	-15,735 Reduced 16.52%	79,487 $9.06 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $154,318 - $172,258	1,532 Added 1.64%	95,222 $9.89 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $253,648 - $280,143	-2,316 Reduced 2.41%	93,690 $10.6 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $115,713 - $141,643	-1,283 Reduced 1.32%	96,006 $10.6 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $173,004 - $207,576	-1,811 Reduced 1.83%	97,289 $9.42 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $12 Million - $13.3 Million	-118,844 Reduced 54.53%	99,100 $10.8 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $427,443 - $503,126	4,413 Added 2.07%	217,944 $22.1 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.15 Million - $1.35 Million	12,100 Added 6.01%	213,531 $23.4 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.38 Million - $1.59 Million	14,233 Added 7.6%	201,431 $19.5 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $2.39 Million - $2.89 Million	23,395 Added 14.28%	187,198 $20.3 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $34.6 Million - $42.2 Million	-303,631 Reduced 64.96%	163,803 $19.4 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $27.8 Million - $34.1 Million	240,793 Added 106.24%	467,434 $65.8 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $27,765 - $30,716	-238 Reduced 0.1%	226,641 $26.8 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $3.87 Million - $4.56 Million	36,586 Added 19.23%	226,879 $26.3 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $131,696 - $155,158	1,210 Added 0.64%	190,293 $22.8 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $42,105 - $45,882	401 Added 0.21%	189,083 $20.7 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $8,705 - $10,572	-95 Reduced 0.05%	188,682 $20.5 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $485,606 - $621,516	-6,342 Reduced 3.25%	188,777 $17.3 Million
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $42,089 - $61,546	670 Added 0.34%	195,119 $15.4 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $282,636 - $314,640	-3,600 Reduced 1.82%	194,449 $16.9 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $16.2 Million - $17.6 Million	198,049 New	198,049 $16.6 Million
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $14.9 Million - $18 Million	-225,439 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $154,721 - $175,277	-2,360 Reduced 1.04%	225,439 $16.3 Million
Q3 2018 Oct 15, 2018	SELL	$60.81 - $73.36 $87,870 - $106,005	-1,445 Reduced 0.63%	227,799 $16.7 Million
Q2 2018 Aug 01, 2018	SELL	$57.57 - $63.54 $72,710 - $80,251	-1,263 Reduced 0.55%	229,244 $14 Million
Q1 2018 Apr 20, 2018	BUY	$56.27 - $63.62 $6.05 Million - $6.84 Million	107,578 Added 87.51%	230,507 $13.8 Million
Q4 2017 Jan 22, 2018	SELL	$53.68 - $57.47 $53,680 - $57,470	-1,000 Reduced 0.81%	122,929 $7.02 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $5.96 Million - $6.65 Million	123,929	123,929 $6.61 Million

Others Institutions Holding ABT

# of Institutions

3,303

Shares Held

1.34B

Call Options Held

9.84M

Put Options Held

8.59M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Abbott Laboratories Transaction History